T. Rowe Price Associates’s Beta Bionics, Inc. Common Stock BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.63M Sell
317,943
-318,261
-50% -$4.63M ﹤0.01% 1294
2025
Q1
$7.79M Buy
+636,204
New +$7.79M ﹤0.01% 1159